EMIRATES DRUG ESTABLISHMENT AND ARCERA SIGN AGREEMENT TO ADVANCE PHARMACEUTICAL MANUFACTURING IN THE UAE

The partnership establishes a framework to strengthen local manufacturing, develop talent, and support long-term supply resilience.

ABU DHABI, UNITED ARAB EMIRATES, MAY 5, 2026 – The Emirates Drug Establishment (“EDE”) and Arcera Life Sciences (“Arcera”) today announced the signing of a Memorandum of Understanding (MoU) to strengthen pharmaceutical manufacturing capabilities in the UAE. Signed at Make it in the Emirates, taking place May 4-7, 2026 at ADNEC Centre Abu Dhabi, the agreement establishes a framework for collaboration across local manufacturing, talent development, research and innovation, and the strategic supply of medical products.

Under the MoU, both parties will work together to advance capacity building and Emiratization within the UAE’s pharmaceutical sector. This includes training programs, technical exchanges, workshops, and industry initiatives aimed at equipping Emirati talent with the skills required for advanced manufacturing environments.